Skip to main content

Table 4 Predictors of length of stay after lobectomy for lung cancer in both sugammadex and pyridostigmine cohorts. Variables were selected from multivariable poisson regression model using forward selection and backward elimination based on the Akaike information criterion

From: Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study

  Exp Coef (95% CI) p value
Demographic predictors
 Age ≥ 65 yr 1.09 (1.10–1.18) 0.021
 Male sex 1.27 (1.16–1.38) < 0.001
 Diabetes mellitus 0.82 (0.75–0.90) < 0.001
 COPD 1.33 (1.23–1.43) < 0.001
Intra- or postoperative predictors
 Sugammadex (vs. pyridostigmine) 0.88 (0.82–0.95) < 0.001
 Dyspnea 1.39 (1.27–1.55) < 0.001
 Atelectasis 1.21 (1.12–1.30) < 0.001
 Pneumonia 1.77 (1.58–1.99) < 0.001
 Air leak > 5 days 1.40 (1.33–1.46) < 0.001
  1. Exp Coef Exponential coefficient, CI Confidence interval, COPD Chronic obstructive pulmonary disease